Track topics on Twitter Track topics that are important to you
The purpose of the Post Approval Study of the ABC and Trident systems is to continue to demonstrate the safety and efficacy of the alumina-on-alumina bearing surfaces combined with the appropriate shell in a cementless application.
The ABC/ Trident study was initiated in 1996 as an FDA IDE Pre-market study in the United States for alumina bearings that were ultimately approved via PreMarket Approval application in February of 2003. The study design was a prospective, multicenter, randomized, controlled clinical investigation. Six surgeons participated in both the ABC and Trident arms of the study and have the longest follow-up data. A subset of patients from the original study who consented to continue participation in the FDA Post Approval Study (PAS) continue to be followed to collect limited patient reported data regarding status of the hip. A total of 518 cases [310 ABC Study cases (214 ceramic / 96 control), 208 Trident cases] were active in the IDE study (IDE #G960148) as of March 12, 2003, when that study ended and the post-approval study began. There were 464 cases who originally agreed to participate in the PAS phase. Of the 464, there are 274 ABC (185 ABC ceramic cases, 89 control cases) and 190 Trident cases.
To continue to demonstrate safety the incidence of revisions and complications will be reported annually to 10 years. To demonstrate efficacy the overall functional performance, pain relief, range of motion, and radiographic evaluation will be measured at 7 and 10 years. Patient satisfaction as well as general health assessments will be completed at 7 and 10 years.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Arthroplasty, Replacement, Hip
Ceramic Post Approval
Orthopaedic Surgery Associates
Active, not recruiting
Published on BioPortfolio: 2014-08-27T03:19:57-0400
This Post-Approval study is prospective follow-up study designed to evaluate the long-term safety and effectiveness of the Reflection Ceramic Acetabular System.
This study will evaluate a midterm clinical and radiologic outcome patients who undergo new alumina-zirconia composite ceramic bearing THA.
The purpose of this study is to collect and evaluate long-term safety and effectiveness data on the Exactech® NOVATION ™ Ceramic Articulation Hip System ("NOVATION ™ Ceramic AHS"). Ten ...
Post-Approval Study (PMA CoA) in Order to Obtain Additional Long Term Safety and Effectiveness Data
This is a prospective, non-randomized, consecutive series, multicentre, observational study to evaluate the clinical outcome of ceramic-on- ceramic hip resurfacing arthroplasty using the c...
The use of Ceramic-on-Ceramic (CoC) bearings in primary total hip arthroplasty (THA) is increasing and has been intensively analysed. This bearing plays a particularly relevant role in young, active p...
Ceramic-on-ceramic articulation shows the lowest wear, with a low incidence of osteolysis. A small cup limits options regarding liner thickness and femoral implant size. The purpose of this study was ...
Postoperative squeaking in patients who applied the fourth-generation ceramic bearing in primary hip replacement has not been reported systematically; we aim to study the squeaking incidence in the fo...
The aim of this open-label, prospective, short-term study was to carry out an initial comparison of a completely metal-free ceramic with a geometrically identical metallic arthroplasty over a 1-year f...
The amount of drug exposure, pre and post approval, is considered to be a direct determinant of knowledge about the safety of a drug. A larger pre-approval exposed population is supposed to reduce the...
Partial or total replacement of a joint.
Replacement of the hip joint.
Partial or total replacement of one or more FINGERS, or a FINGER JOINT.
Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.
Replacement of the SHOULDER JOINT.
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...